These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25196058)

  • 1. EpsinR, a target for pyrenocine B, role in endogenous MHC-II-restricted antigen presentation.
    Shishido T; Hachisuka M; Ryuzaki K; Miura Y; Tanabe A; Tamura Y; Kusayanagi T; Takeuchi T; Kamisuki S; Sugawara F; Sahara H
    Eur J Immunol; 2014 Nov; 44(11):3220-31. PubMed ID: 25196058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells.
    Tardif V; Riquelme SA; Remy S; Carreño LJ; Cortés CM; Simon T; Hill M; Louvet C; Riedel CA; Blancou P; Bach JM; Chauveau C; Bueno SM; Anegon I; Kalergis AM
    Eur J Immunol; 2013 Nov; 43(11):2832-44. PubMed ID: 23852701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.
    Crotzer VL; Glosson N; Zhou D; Nishino I; Blum JS
    Immunology; 2010 Nov; 131(3):318-30. PubMed ID: 20518820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.
    Bosch B; Berger AC; Khandelwal S; Heipertz EL; Scharf B; Santambrogio L; Roche PA
    J Biol Chem; 2013 Aug; 288(34):24286-92. PubMed ID: 23846690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
    Becker HJ; Kondo E; Shimabukuro-Vornhagen A; Theurich S; von Bergwelt-Baildon MS
    Eur J Haematol; 2016 Aug; 97(2):166-74. PubMed ID: 26561366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
    de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
    Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b.
    Michelet X; Garg S; Wolf BJ; Tuli A; Ricciardi-Castagnoli P; Brenner MB
    J Immunol; 2015 Mar; 194(5):2079-88. PubMed ID: 25637027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
    Storni T; Bachmann MF
    J Immunol; 2004 May; 172(10):6129-35. PubMed ID: 15128799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells.
    Majewski M; Bose TO; Sillé FC; Pollington AM; Fiebiger E; Boes M
    Int Immunol; 2007 Jun; 19(6):719-32. PubMed ID: 17446207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
    Rosalia RA; Quakkelaar ED; Redeker A; Khan S; Camps M; Drijfhout JW; Silva AL; Jiskoot W; van Hall T; van Veelen PA; Janssen G; Franken K; Cruz LJ; Tromp A; Oostendorp J; van der Burg SH; Ossendorp F; Melief CJ
    Eur J Immunol; 2013 Oct; 43(10):2554-65. PubMed ID: 23836147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51.
    Imai A; Sahara H; Tamura Y; Jimbow K; Saito T; Ezoe K; Yotsuyanagi T; Sato N
    Eur J Immunol; 2007 Jul; 37(7):1730-8. PubMed ID: 17523132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.
    Schmid D; Pypaert M; Münz C
    Immunity; 2007 Jan; 26(1):79-92. PubMed ID: 17182262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
    Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
    Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do T cells need endogenous peptides for activation?
    Gascoigne NR
    Nat Rev Immunol; 2008 Nov; 8(11):895-900. PubMed ID: 18846098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW; Ratner DM; Seeberger PH; Hacohen N
    Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells.
    Lee YH; Lee YR; Kim KH; Im SA; Song S; Lee MK; Kim Y; Hong JT; Kim K; Lee CK
    Int Immunopharmacol; 2011 Aug; 11(8):985-91. PubMed ID: 21354357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.